Castle Biosciences, Inc. (CSTL)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Loading interactive chart…
- Business Wire
Castle Biosciences to Present Data at Maui Derm for Dermatologists 2022
FRIENDSWOOD, Texas, January 24, 2022--Castle Biosciences will present data highlighting its portfolio of skin cancer tests at Maui Derm for Dermatologists 2022, Jan. 24-28, 2022.
- Business Wire
Recently Published Data Confirm DecisionDx®-SCC as a Significant and Independent Risk-Stratification Tool in Patients with Squamous Cell Carcinoma and One or More Risk Factors
FRIENDSWOOD, Texas, January 13, 2022--Castle announced the publication of clinical performance study data related to DecisionDx®-SCC in Future Oncology.
- Business Wire
Data Published in Ocular Oncology and Pathology Demonstrates Highly Accurate Performance of DecisionDx®-UMSeq for Patients with Uveal Melanoma
FRIENDSWOOD, Texas, January 12, 2022--Castle announced the publication of a study in Ocular Oncology and Pathology related to the Company's DecisionDx®-UMSeq 7-gene DNA sequencing panel.
© 2022 Yahoo. All rights reserved.
